FDA clears Ascent reprocessed Biosense circular mapping catheter

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Ascent Healthcare Solutions reported it is the first company to receive 510(k) clearance from the FDA to reprocess the Lasso 2515 variable circular mapping catheter manufactured by Biosense Webster.

The average price for reprocessed circular mapping catheters is $700, compared with the national average cost of $1,500-$1,650 when the devices are purchased directly from the original manufacturer, according to the Phoenix-based company.

The Biosense Webster LASSO 2515 variable circular mapping catheter has been designed to facilitate electrophysiological mapping of the atria of the heart and is deployed in the right or left atrium, Ascent said. The catheter features a variable loop that adjusts to veins sized between 25 and 15 mm. Its adjustable tip provides mapping and is also deflectable for maximum movement.